Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study

Jonathan A. Bernstein, Stephen D. Betschel, Paula J. Busse, Aleena Banerji, H. James Wedner, Michael Manning, Rafael H. Zaragoza-Urdaz, John Anderson, Remi Gagnon, Alan P. Baptist, Daniel Soteres, William R. Lumry, Timothy Craig, Daniel Petroni, F. Ida Hsu, Daniel Nova Estepan, Salomé Juethner, Maureen Watt, Natalie Khutoryansky, Bruce L. Zuraw, Unknown, Alan P Baptist, Paula J Busse, Hugo Chapdelaine, Selina Gierer, M. Dawn Goodyear, Douglas Johnston, Jay Kashkin, Paul K. Keith, Alexander Kim, H. Henry Li, Richard Lockey, Patricia Lugar, Jason Raasch, Raffi Tachdjian, Mark Weinstein

Open source

DOI: 10.1007/s12325-025-03226-3
Published: 2025-06-12
Container: Advances in Therapy
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12325-025-03226-3,
  title = {Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study},
  author = {Jonathan A. Bernstein and Stephen D. Betschel and Paula J. Busse and Aleena Banerji and H. James Wedner and Michael Manning and Rafael H. Zaragoza-Urdaz and John Anderson and Remi Gagnon and Alan P. Baptist and Daniel Soteres and William R. Lumry and Timothy Craig and Daniel Petroni and F. Ida Hsu and Daniel Nova Estepan and Salomé Juethner and Maureen Watt and Natalie Khutoryansky and Bruce L. Zuraw and Unknown and Alan P Baptist and Paula J Busse and Hugo Chapdelaine and Selina Gierer and M. Dawn Goodyear and Douglas Johnston and Jay Kashkin and Paul K. Keith and Alexander Kim and H. Henry Li and Richard Lockey and Patricia Lugar and Jason Raasch and Raffi Tachdjian and Mark Weinstein},
  year = {2025},
  journal = {Advances in Therapy},
  doi = {10.1007/s12325-025-03226-3},
  url = {https://doi.org/10.1007/s12325-025-03226-3}
}

RIS

TY  - JOUR
TI  - Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study
AU  - Jonathan A. Bernstein
AU  - Stephen D. Betschel
AU  - Paula J. Busse
AU  - Aleena Banerji
AU  - H. James Wedner
AU  - Michael Manning
AU  - Rafael H. Zaragoza-Urdaz
AU  - John Anderson
AU  - Remi Gagnon
AU  - Alan P. Baptist
AU  - Daniel Soteres
AU  - William R. Lumry
AU  - Timothy Craig
AU  - Daniel Petroni
AU  - F. Ida Hsu
AU  - Daniel Nova Estepan
AU  - Salomé Juethner
AU  - Maureen Watt
AU  - Natalie Khutoryansky
AU  - Bruce L. Zuraw
AU  - Unknown
AU  - Alan P Baptist
AU  - Paula J Busse
AU  - Hugo Chapdelaine
AU  - Selina Gierer
AU  - M. Dawn Goodyear
AU  - Douglas Johnston
AU  - Jay Kashkin
AU  - Paul K. Keith
AU  - Alexander Kim
AU  - H. Henry Li
AU  - Richard Lockey
AU  - Patricia Lugar
AU  - Jason Raasch
AU  - Raffi Tachdjian
AU  - Mark Weinstein
PY  - 2025
JO  - Advances in Therapy
DO  - 10.1007/s12325-025-03226-3
UR  - https://doi.org/10.1007/s12325-025-03226-3
ER  -

APA

Bernstein, J. A., Betschel, S. D., Busse, P. J., Banerji, A., Wedner, H. J., Manning, M., Zaragoza-Urdaz, R. H., Anderson, J., Gagnon, R., Baptist, A. P., Soteres, D., Lumry, W. R., Craig, T., Petroni, D., Hsu, F. I., Estepan, D. N., Juethner, S., Watt, M., Khutoryansky, N., Zuraw, B. L., Unknown, Baptist, A. P., Busse, P. J., Chapdelaine, H., Gierer, S., Goodyear, M. D., Johnston, D., Kashkin, J., Keith, P. K., Kim, A., Li, H. H., Lockey, R., Lugar, P., Raasch, J., Tachdjian, R., & Weinstein, M. (2025). Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study. Advances in Therapy. https://doi.org/10.1007/s12325-025-03226-3

Source records

crossref · retrieved 2026-09-25T19:28:23.683Z